Recibokibart, an Anti-Il-36 Receptor Monoclonal Antibody, for Treating Generalized Pustular Psoriasis: Phase 1b Trial.
Journal of the European Academy of Dermatology and Venereology JEADV(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined